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Introduction
The function of proteins involved in extracellular signaling 
depends on their regulated secretion in response to the appro­
priate stimuli. Regulated secretion contributes to the roles of pep­
tide hormones such as insulin, neural peptides such as opioids, 
and growth factors such as brain­derived neurotrophic factor. 
Thus, the regulated release of proteins has a central role in   
human disease and normal physiology, synaptic plasticity,   
behavior, and development.
The regulated secretion of proteins requires their sorting 
into a specialized secretory pathway capable of regulated exo­
cytosis, the regulated secretory pathway (RSP). In contrast to 
the constitutive secretory pathway, which confers the immedi­
ate release of newly synthesized proteins from essentially all 
eukaryotic cells, the RSP enables release from specialized cells 
in response to physiologically appropriate signals. However, we 
know very little about how proteins sort into the regulated rather 
than the constitutive pathway.
Morphologically,  the  RSP  usually  corresponds  to  large 
vesicles containing a dense core of aggregated cargo. These large 
dense­core vesicles (LDCVs) bud from the TGN (Orci et al., 
1987; Tooze and Huttner, 1990; Eaton et al., 2000), and lumenal 
interactions such as the aggregation of granulogenic proteins 
have been suggested to drive their formation (Kim et al., 2001; 
Turkewitz, 2004). Previous work has also suggested that sorting 
to LDCVs occurs by default, with proteins destined for other   
organelles removed during the subsequent, well­established pro­
cess of LDCV maturation (Arvan and Castle, 1998; Morvan and 
Tooze, 2008). However, the direct analysis of budding from the 
TGN has demonstrated the sorting of regulated from constitutive 
cargo at this step, before maturation (Tooze and Huttner, 1990). 
LDCV membrane proteins such as carboxypeptidase E and   
sortilin may serve as the receptors for soluble cargo (Cool et al., 
1997; Chen et al., 2005). In contrast to these lumenal interactions, 
we know little about any cytosolic machinery like those that gener­
ate transport vesicles from essentially all of the other membrane 
compartments in eukaryotic cells.
Several membrane proteins contain cytosolic sequences 
that direct them to LDCVs. In the case of the enzyme peptidyl­
glycine ­amidating monooxygenase and the endothelial adhe­
sion molecule P­selectin, however, these sequences are not 
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capable of regulated exocytosis. LDCVs form at the 
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screen in Drosophila melanogaster S2 cells, we now   
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units of the heterotetrameric adaptor protein AP-3, which 
are required for sorting to the RSP. In mammalian neuro-
endocrine cells, loss of AP-3 dysregulates exocytosis due 
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alanine (DE/AA mutation) using a lumenal HA epitope tag to 
assess surface expression (Greer et al., 2005) and a fusion of 
GFP to the N terminus of dVMAT to determine the total amount 
of protein expressed. S2 cells were incubated for 2 h with HA 
antibody conjugated to Alexa Fluor 647, and flow cytometry 
was  used  to  quantify  the  fluorescence  of  individual  cells.   
Despite equivalent total dVMAT expression, we observed very 
low cell surface delivery of wt dVMAT relative to the DE/AA 
mutant. A scatter plot shows that DE/AA dVMAT has a much 
higher ratio of Alexa Fluor 647 to GFP fluorescence than wt 
(Fig. 1 A), with an approximately sevenfold difference in mean 
surface/total transporter, and P < 10
14 by Kolmogorov­Smirnov 
analysis of the cumulative frequency distribution for ratios from 
individual cells (Fig. 1 B). Because the analogous mutation in 
rat VMAT2 has a very similar effect on cell surface expression 
and selectively disrupts sorting to the RSP (Krantz et al., 1997; 
Li et al., 2005), we infer that S2 cells must express some of the 
same sorting machinery.
We then determined whether S2 cells can in fact mediate 
regulated secretion using a fusion of GFP to mammalian atrial 
natriuretic factor (ANF) because this peptide hormone has   
been shown to undergo regulated exocytosis in Drosophila   
(Shakiryanova et al., 2005). As control, we fused GFP directly 
to the signal sequence (ss) of ANF. Measurement of fluores­
cence in the supernatant shows an approximately fivefold less 
basal secretion of ANF­GFP than ss­GFP even after normaliza­
tion to total GFP expression (Fig. 1 C), indicating efficient stor­
age of ANF. To determine whether S2 cells can release ANF in 
a regulated manner, we stimulated cells expressing ANF­GFP 
for 1 h with lipopolysaccharide (LPS). LPS increases secretion 
of ANF­GFP by about twofold (Fig. 1 D), and this effect is 
blocked by the removal of external Ca
2+ (Fig. 1 E). LPS also has 
no effect on secretion of ss­GFP (Fig. 1 D), which is consistent 
with the constitutive release of this protein. In addition, because 
LDCVs differ from other secretory vesicles in their dependence 
on the calcium­dependent activator protein for secretion (Martin 
and Walent, 1989; Berwin et al., 1998; Elhamdani et al., 1999; 
Speese et al., 2007), we used double­stranded RNA (dsRNA)   
to knock down the Drosophila orthologue and found that this 
eliminates regulated release of ANF from S2 cells (Fig. 1 F). S2 
cells thus express a functional RSP. Colocalization of mCherry­
dVMAT with ANF­GFP but not ss­GFP (Fig. S1) further sup­
ports the sorting of dVMAT to this pathway.
An RNAi screen in S2 cells identifies  
genes that regulate cell surface  
dVMAT expression
To identify cellular machinery involved in biogenesis of the RSP, 
we performed a genome­wide RNAi screen in S2 cells using a   
library of 7,216 sequences that target Drosophila genes conserved 
to mammals. S2 cells transfected with GFP­dVMAT­HA were 
seeded into 96­well plates and treated twice with dsRNA. After 
treatment for 6 d, the cells were incubated with HA antibody con­
jugated to Alexa Fluor 647 and assayed for antibody uptake and 
total  expression  by  high­throughput  flow  cytometry,  enabling   
individual  measurements  from  many  cells  for  each  condition   
(Fig. 2 A). The ratio of surface/total dVMAT was computed for 
required for sorting to the RSP because lumenal interactions 
suffice (Blagoveshchenskaya et al., 2002; Harrison­Lavoie   
et al., 2006). However, the neuronal vesicular monoamine trans­
porter 2 (VMAT2), which fills LDCVs and synaptic vesicles with 
monoamines, depends on a conserved C­terminal cytoplasmic 
dileucine­like  motif  (KEEKMAIL)  for  sorting  to  LDCVs   
(Liu  et  al.,  1994;  Erickson  et  al.,  1995).  Mutation  of  the 
dileucine­like core (bold letters) disrupts multiple trafficking 
events including endocytosis, but replacement of the upstream 
acidic residues (Glu­478 and ­479 [italic letters above]) with   
alanine (EE/AA mutation) diverts VMAT2 from the regulated to 
the constitutive secretory pathway, increasing cell surface deliv­
ery without affecting endocytosis (Krantz et al., 1997). Glu­478 
and ­479 thus appear to have a specific role in sorting to the 
RSP, and the LDCV membrane protein phogrin contains a re­
markably  similar  sequence  also  required  for  localization  to   
LDCVs (Torii et al., 2005). Because VMAT2 does not appear at 
the cell surface before sorting to LDCVs (Li et al., 2005), the   
motif presumably acts within the biosynthetic rather than endo­
cytic pathway, most likely at the level of the TGN, where LDCVs   
form. The requirement for a cytoplasmic motif in sorting to the 
RSP further suggests an interaction with cytosolic sorting   
machinery. Indeed, we have now used VMAT as a reporter to 
identify genes involved in biogenesis of the RSP.
Results
The increased plasma membrane expression of EE/AA VMAT2 
caused by its diversion from the regulated to constitutive secre­
tory pathway (Krantz et al., 2000) suggested that cellular de­
fects in sorting to the RSP might similarly increase the surface 
delivery of wild­type (wt) VMAT2. We have thus used the cell 
surface exposure of VMAT to screen for genes involved in bio­
genesis of the RSP. Although endocytosis might be expected to 
influence cell surface expression, direct sorting of VMAT2 to 
the RSP at the level of the TGN, without passage through the 
plasma membrane (Li et al., 2005), should minimize the chance 
of identifying genes involved in endocytosis. Screening for   
increased surface delivery should also reduce the likelihood of 
identifying genes with nonspecific deleterious effects.
Drosophila melanogaster S2 cells exhibit 
an RSP
Drosophila S2 cells are very sensitive to RNAi and have been 
used to screen for genes involved in a wide range of cellular 
processes  (Foley  and  O’Farrell,  2004;  Bard  et  al.,  2006;   
Goshima et al., 2007; Guo et al., 2008), but it is not known 
whether S2 cells express sorting machinery that can recognize 
the dileucine­like motif in VMAT. However, even constitutive 
secretory cells such as Chinese hamster ovary cells have been 
suggested to express a cryptic pathway for regulated secretion 
(Chavez et al., 1996). To test this possibility in S2 cells, we used 
Drosophila VMAT (dVMAT), which contains a dileucine­like 
motif (SDEKKSLI) remarkably similar to the mammalian se­
quence, with two acidic residues (italics) 4 and 5 positions up­
stream of the dileucine (bold; Greer et al., 2005). We replaced 
the upstream acidic residues (Asp­584 and Glu­585) with   1175 Biogenesis of the regulated secretory pathway • Asensio et al.
screen identified nine proteins with a primary role in membrane 
trafficking, including four cytoskeletal proteins or enzymes   
implicated in the regulation of membrane trafficking, and two 
proteins  of  unknown  function  (Table  I).  Because  the  genes 
identified may influence VMAT surface expression through a 
variety of mechanisms, including some unrelated to the RSP, 
we then performed a series of secondary screens.
Dependence on the VMAT sorting motif
To determine whether the effect of genes identified in the screen 
depends on the VMAT dileucine­like motif, we examined their 
interaction with the DE/AA mutation. Class I genes increase HA 
antibody uptake by DE/AA and wt dVMAT (Fig. 3, top), suggesting 
that they act independently of the extended dileucine. Mech­
anisms that might account for the additive effect include an im­
pairment of endocytosis and an increase in constitutive secretion.   
each cell, and a z score was calculated relative to other wells in 
the same plate as controls. The entire screen was performed twice, 
once using transiently transfected S2 cells and a second time with 
stable transformants. After removing genes that reduced the num­
ber of cells available for analysis or that influenced expression of 
the GFP­tagged reporter (Table S1), we focused on the remaining 
positives from both screens with z score ≥3. Because essentially 
all of the excluded genes affect transcription or translation, we 
excluded a small number of additional sequences because they 
also involve transcription or translation.
We retested the remaining 18 genes with nonoverlapping 
dsRNA sequences to exclude false positives caused by off­target 
effects. In at least two of four independently performed experi­
ments, we confirmed the increase in dVMAT surface expression 
for 16 of the 18 genes (P < 0.003 by Kolmogorov­Smirnov analysis 
of the cumulative frequency distributions; Fig. 3). Remarkably, the 
Figure 1.  S2 cells express an RSP. (A and B) S2 cells were transiently transfected with wt (black) or DE/AA (red) GFP- and HA-tagged dVMAT, incubated 
for 2 h at room temperature with external HA antibody conjugated to Alexa Fluor 647, washed, and the fluorescence of individual cells was determined 
by flow cytometry (A). (inset) The bar graph displays the mean ratio of surface/total fluorescence (n > 1,800 cells). Kolmogorov-Smirnov analysis of the   
cumulative frequency distributions binned by surface/total dVMAT ratios (B) indicates a significant change in the DE/AA distribution relative to wt   
(***, P < 10
14). (C–F) S2 cells were transiently transfected with ANF-GFP (C–E) or the signal sequence of ANF fused directly to GFP (ss-GFP; C and D), 
washed, incubated for 1 h, and the cellular and secreted GFP fluorescence were measured using a plate reader. (C) Normalized to intracellular fluores-
cence, the media of cells expressing ANF-GFP shows less fluorescence than cells expressing ss-GFP. (D) Treatment with 100 µg/ml LPS induces secretion of 
ANF-GFP but not ss-GFP. (E and F) Pretreatment with BAPTA-AM in calcium-free buffer (E) or knockdown of Drosophila calcium-dependent activator protein 
for secretion (dCAPS) with dsRNA (F) block the secretion evoked by LPS. *, P < 0.05 by two-tailed Student’s t test. The data represent mean values from 
three to four independent experiments, and error bars indicate SEM.JCB • VOLUME 191 • NUMBER 6 • 2010   1176
(Fig.  3,  middle).  Because  dsRNA  to  these  sequences  in­
creases antibody uptake by wt dVMAT, an opposite effect on 
the mutant might appear surprising. However, the discrep­
ancy may simply reflect a role for these proteins in constitu­
tive and regulated secretion, with targeting to the constitutive 
pathway making DE/AA dVMAT more sensitive than wt to 
the RNAi. Consistent with this possibility and partial knock­
down by the dsRNA, complete block of the secretory path­
way with brefeldin A significantly reduces DE/AA dVMAT 
surface expression without any discernible effect on the low 
surface levels of wt dVMAT (unpublished data). In addition, 
a screen for genes important in constitutive secretion has al­
ready identified rab1 and arf79F (homologous to Arf1 in mam­
mals; Bard et al., 2006), and we find that their knockdown 
decreases constitutive secretion of ANF­GFP (Fig. 3, middle). 
Class II genes may thus have roles in both regulated and con­
stitutive pathways.
Class III genes show no additional effects on HA antibody 
uptake by DE/AA dVMAT (Fig. 3, bottom), suggesting their 
Indeed, we identified the µ subunit of adaptor protein AP­2   
(µ2) presumably because it has an important role in clathrin­ 
dependent endocytosis, and knockdown would be expected to   
increase cell surface expression of DE/AA dVMAT because the 
mutant resides at higher levels than wt at the plasma membrane. 
It is more surprising that knockdown of AP­2 increases HA anti­
body uptake by wt dVMAT considering the low rate of its deliv­
ery to the plasma membrane, but we did not identify other proteins 
known to be involved in endocytosis. To determine whether the 
knockdown of other class I genes increases cell surface dVMAT 
by promoting constitutive secretion, we examined the basal re­
lease over 1 h of ANF­GFP from unstimulated S2 cells. dsRNA 
to the catalytic subunit of protein phosphatase 1 (PP1), sec20, and 
particularly rhoC all significantly increased release of ANF­GFP 
(Fig. 3, top middle), and the role of sec20 in retrograde transport 
from Golgi to endoplasmic reticulum presumably accounts for 
the effect of dsRNA to this gene (Lewis et al., 1997).
Knockdown  of  class  II  genes  (rab1,  arf79F,  and 
cg32687) reduces HA antibody uptake by DE/AA dVMAT 
Figure 2.  S2 cell screen identifies genes that regulate the surface expression of dVMAT. (A) The flow chart illustrates the procedure used for screening. 
S2 cells transfected with GFP-/HA-dVMAT were treated twice with dsRNA over a 6-d period in a 96-well plate, incubated with external HA antibody 
conjugated to Alexa Fluor 647 for 2 h, washed, and the fluorescence of both GFP and Alexa Fluor 647 was measured at the level of individual cells by 
flow cytometry. Of 7,200 genes conserved from Drosophila to mammals, 18 positives (z score ≥ 3) were identified and retested using nonoverlapping 
dsRNA. Kolmogorov-Smirnov analysis of the cumulative frequency distribution reveals that 16 of 18 genes were again positive (P < 0.005 in at least two 
independent experiments). (B) Cumulative frequency distributions for selected dsRNA in representative retest experiments show the differences from control 
(wt) and DE/AA dVMAT.1177 Biogenesis of the regulated secretory pathway • Asensio et al.
To determine whether genes identified in the screen actually 
impair the regulated secretion of soluble cargo as well as the 
sorting of a polytopic membrane protein, we examined the regu­
lated release of ANF­GFP in response to stimulation with LPS. 
Most of the genes identified do not affect the regulation of release, 
suggesting either independent effects on cell surface expression 
of VMAT or differential effects on the sorting of membrane and 
soluble cargo. However, knockdown of two class I (nup93 and 
pp1-13C) and two class III genes (garnet and cg8945) do abolish 
regulated release (Fig. 3). The screen has thus identified a small 
number of genes required for regulated secretion.
dependence on the extended dileucine motif. Indeed, Scy1­like 
kinase and N­acetylglucosamine (GlcNAc)–1­phosphotransferase 
have been implicated in trafficking through the Golgi com­
plex, back to the endoplasmic reticulum and to lysosomes, re­
spectively (Tiede et al., 2005; Burman et al., 2008). However, 
RNAi to Scy1­like kinase or GlcNAc­1­phosphotransferase does 
not increase constitutive release of ANF­GFP (Fig. 3, bottom 
middle). In contrast, two other dsRNAs in this class (garnet  
and derlin) increase the constitutive release of ANF, which is   
consistent with diversion of this soluble protein from the regu­
lated to the constitutive pathway.
Figure 3.  Classification of genes identified in the screen by mechanism and effect on the regulated secretion of soluble cargo. S2 cells transfected with 
DE/AA GFP-/HA-dVMAT were treated with dsRNA-targeting genes identified in the screen, and the uptake of external HA antibody was measured as 
described in Fig. 1. (left) Representative cumulative frequency distributions are shown for selected genes in each class. Class I genes increase, class II genes 
decrease, and class III genes have no effect on antibody uptake by DE/AA dVMAT. (middle) S2 cells expressing ANF-GFP were treated with dsRNA and 
basal (unstimulated) secretion of GFP fluorescence determined as in Fig. 1 C. Secretion was normalized to cellular ANF-GFP and expressed as a percent-
age of the fluorescence secreted by control cells. (right) S2 cells expressing ANF-GFP were treated with dsRNA and LPS-induced secretion measured as in 
Fig. 1 D. *, P < 0.05; **, P < 0.01 (relative to control by two-tailed Student’s t test; n = 3–5). The data show mean values, and error bars indicate SEM.JCB • VOLUME 191 • NUMBER 6 • 2010   1178
confirmed positive on specific retesting, and the fourth subunit 
(orange) was not present in the library. AP­3 is known to play a 
role in the formation of lysosome­related organelles (LROs) 
such as melanosomes and platelet­dense granules, in addition   
to synaptic vesicles (Newell­Litwa et al., 2007). Similar to   
Loss of AP-3 dysregulates secretion from 
mammalian neuroendocrine cells
Remarkably,  two  genes  identified  in  the  screen  (garnet  and 
ruby) encode subunits of the heterotetrameric AP­3 complex. 
The third subunit of AP­3 present in the library (carmine) was 
Table I.  Genes identified in the S2 cell screen and confirmed with nonoverlapping dsRNA
Cg Gene symbol Homologue/domain Z score Class
8416 Rho1 RhoC 5.8 I
2023 Cg2023 Sec20 3.6 I
7057 AP-50 AP-2µ1 3.2 I
7262 Cg7262 Nucleoporin 93 3.0 I
9156 PP1-13C PP1cc 3.0 I
3320 Rab1 Rab1A 3.8 II
8385 Arf79F Arf1 3.3 II
32687 Cg32687 Leucine-rich repeat 58 3.0 II
11427 Ruby AP-32 3.8 III
11197 Garnet AP-31 3.7 III
8945 Cg8945 Carboxypeptidase 3.4 III
14899 Cg14899 Derlin-2 3.3 III
3201 Mlc-c Myosin light chain 3.3 III
4707 Cg4707 Zinc finger 3.1 III
1973 Yata Scy1-like kinase 3.0 III
8027 Cg8027 GlcNAc-1-phosphotransferase (
/
) 3.0 III
List of genes identified as positive in the S2 cell screen using GFP-/HA-tagged dVMAT as reporter. The z score indicates significance assessed using a within-plate 
comparison. Class I dsRNAs increase cell surface expression of DE/AA dVMAT, class II reduce surface expression of the mutant, and class III have no effect.
Figure 4.  AP-3 RNAi increases VMAT2 sur-
face expression and impairs regulated release 
of  SgII  from  PC12  cells.  (A  and  B)  Western 
analysis of extracts from PC12 cells transiently 
transfected with 50 nM AP-3 siRNA show an 
80% reduction in AP-3 subunit 3A rela-
tive to cells transfected with control siRNA (A). 
PC12  cells  cotransfected  with  wt  or  EE/AA 
GFP-/HA-VMAT2 with or without AP-3 siRNA 
were subjected to flow cytometry as described 
in Fig. 1 B. Kolmogorov-Smirnov analysis of 
the  cumulative  frequency  distributions  for  wt 
VMAT2 + control siRNA (gray), wt VMAT2 +   
AP-3  siRNA  (red),  and  EE/AA  VMAT2  + 
control  siRNA  (black)  indicates  a  significant 
change in the AP-3 siRNA distribution relative 
to wt (P < 10
14). (C and D) PC12 cells were 
transiently  transfected  with  AP-3  or  control 
siRNA, washed, and incubated for 30 min in 
Tyrode’s solution containing 2.5 mM (basal) or 
90 mM (stimulated) K
+. Cellular and secreted 
SgII were measured by quantitative fluorescent 
immunoblotting (C), with the secreted SgII nor-
malized to basal secretion in the control (D). 
AP-3 RNAi greatly reduces the depolarization-
induced secretion of SgII. *, P < 0.05 relative 
to  stimulated  secretion  from  control  by  two-
tailed Student’s t test (n = 4). (E) AP-3 RNAi 
reduces the cellular content of SgII relative to 
actin. *, P < 0.005 relative to control by two-
tailed Student’s t test (n = 4). (F) The adrenal 
glands of mocha mice lacking AP-3 show a 
dramatic reduction in the content of SgII and 
chromogranin A (CgA) relative to the adrenals 
of control littermates. *, P < 0.05; **, P < 0.005 
(relative  to  wt  by  two-tailed  Student’s  t  test;   
n = 3). The data show mean values, and error 
bars indicate SEM.1179 Biogenesis of the regulated secretory pathway • Asensio et al.
and chromogranin A show a dramatic reduction in mocha mice 
(to 5% and 20% of wt animals, respectively; Fig. 4 F), which 
is consistent with the results from PC12 cells, and excluding   
an off­target effect of the RNAi. Identified in Drosophila S2 
cells as important for sorting to the RSP, AP­3 thus has a similar 
role in the regulated exocytosis of both membrane and soluble 
cargo by mammalian neuroendocrine cells.
A previous study has shown that the loss of AP­3 increases 
the amount of monoamine released per vesicle and the size of 
LDCVs, but it did not examine the regulation of release (Grabner 
et al., 2006). To assess the regulated exocytosis of LDCVs, we 
used direct, optical imaging of a reporter based on the ecliptic 
pHluorin (Miesenböck et al., 1998), a modified form of GFP 
that undergoes quenching at the low pH of secretory vesicles and 
thus increases in fluorescence with exocytosis (Sankaranarayanan 
et al., 2000). In particular, we fused the pHluorin to a lumenal 
domain of VMAT2 (Onoa et al., 2010) and monitored individual 
exocytotic events at the plasma membrane of live, transfected 
PC12 cells by total internal reflection fluorescence (TIRF) micros­
copy. Because the low surface expression of VMAT2­pHluorin 
complicates identification of the transfected cells, we alkalinized 
LDCVs, LROs are acidic, and some can undergo regulated exo­
cytosis. However, AP­3 contributes to formation of these organ­
elles from endosomes, whereas LDCVs bud directly from the 
TGN within the biosynthetic pathway (Tooze and Huttner, 1990; 
Eaton et al., 2000).
To assess a role for AP­3 in sorting to the LDCVs of mam­
malian neuroendocrine cells, we used rat pheochromocytoma 
PC12 cells. Knockdown of the sole AP­3  subunit destabilizes 
the complex (Kantheti et al., 1998), reducing the amount of 
3A by 80% (Fig. 4 A) and very substantially increasing HA 
antibody uptake by VMAT2 (Fig. 4 B). In addition, the loss of 
AP­3 greatly impairs the stimulation of SgII (secretogranin II) 
release by depolarization, with little effect on the absolute 
amount of basal release (Fig. 4, C and D). However, because 
AP­3 knockdown reduces the cellular content of SgII (to 35% 
of control cells; Fig. 4 E), constitutive release is in fact increased 
relative to control, which is consistent with diversion from the 
regulated to constitutive pathway.
To determine whether the loss of AP­3 has a similar effect 
on LDCV composition in vivo, we measured the granin content 
of adrenal glands from mocha mice, which lack AP­3. Both SgII 
Figure 5.  AP-3 RNAi dysregulates the exocytosis of VMAT2. PC12 cells were transfected with 50 nM AP-3 or control siRNA, cotransfected 2 d later 
with the same siRNA and VMAT2 containing a lumenal pHluorin (VMAT2-pHluorin), then imaged live by TIRF microscopy after an additional 2 d. Basal 
exocytosis of VMAT2-pHluorin was measured in Tyrode’s solution containing 2.5 mM K
+, and release was stimulated in Tyrode’s with 90 mM K
+ for 60 s. 
(A) Representative images acquired before and after depolarization show increased baseline fluorescence and fewer stimulated events (arrowheads) after 
transfection with AP-3 siRNA (Videos 1 and 2). (B) Total VMAT2 fluorescence was revealed by alkalinization in Tyrode’s solution containing 50 mM NH4Cl, 
pH 7.4 (top), and surface VMAT2-pHluorin revealed by acidification in Tyrode’s with 25 mM MES, pH 6.5 (bottom). AP-3 RNAi increases the surface 
fraction of VMAT2 in cells despite expression equivalent to transfection with control siRNA. *, P < 0.05 relative to control by two-tailed Student’s t test   
(n = 12 for control and 14 for AP-3 siRNA). (C) Whole cell fluorescence expressed as a percentage of total fluorescence (revealed in NH4Cl) shows a robust 
response to depolarization with 90 mM K
+ (arrow) in control cells but a greatly impaired response after AP-3 siRNA. The traces indicate the mean values of 
12 individual traces for control and 14 for AP-3 RNAi cells. (D) The quantification of individual exocytotic events shows increased basal VMAT2-pHluorin 
exocytosis with AP-3 RNAi but a reduction in stimulated exocytosis. *, P < 0.02; **, P < 0.002 (relative to control by two-tailed Student’s t test; control,   
n = 31; AP-3, n = 19). Error bars indicate SEM. Bars, 5 µm.JCB • VOLUME 191 • NUMBER 6 • 2010   1180
Figure 6.  AP-3 RNAi affects the properties of LDCVs. (A and B) PC12 cells were transfected twice with 50 nM AP-3 or control siRNA, and the postnuclear 
supernatant (input) obtained 2–3 d after the second transfection was separated by equilibrium sedimentation through 0.6–1.6 M sucrose. Fractions were 
collected from the top of the gradient and assayed for synaptophysin (syp) and SgII by quantitative fluorescent immunoblotting, with each fraction expressed 
as the percentage of total gradient immunoreactivity, and the area under the LDCV peak (black lines) expressed as a percentage of the area under the entire 
curve (inset). (A) AP-3 RNAi greatly reduces the LDCV peak and shifts the SgII immunoreactivity toward lighter fractions without affecting the synaptic vesicle 
protein synaptophysin. *, P < 0.05 relative to control by two-tailed Student’s t test (n = 3 transfections). (B) PC12 cells were cotransfected with ANF-GFP and 
either AP-3 or control siRNA, and the postnuclear supernatant was sedimented as in A. In this case, however, 80 fractions were collected from the top 
of the gradient directly into a 96-well plate, and the fluorescence of ANF-GFP was measured directly using a plate reader. The graph indicates ANF-GFP 
fluorescence for each fraction expressed as a percentage of total gradient fluorescence. (right) The bar graph shows the area under the curve for the LDCV 1181 Biogenesis of the regulated secretory pathway • Asensio et al.
undergoes constitutive secretion. Analysis of the medium con­
firms the constitutive release of 
35SO4
­HSPG that is unaffected 
by AP­3 RNAi and the dysregulated secretion of 
35SO4
­SgII 
produced by loss of AP­3 (Fig. 7 B). AP­3 thus influences the 
fate of LDCVs rather than constitutive secretory vesicles, which 
is consistent with a specific role in formation of the RSP.
AP­3 might influence either the biogenesis of LDCVs at 
the TGN or the process of maturation after budding that involves 
the removal of proteins destined for other organelles (Morvan 
and Tooze, 2008). The adaptor AP­1 rather than AP­3 has been 
implicated in LDCV maturation (Dittie et al., 1996), but to as­
sess a distinct role for AP­3 in budding from the TGN, we again 
used metabolic labeling with 
35SO4
, allowing only 15 min of 
chase to enable a direct analysis of the newly formed vesicles 
(Tooze and Huttner, 1990). These vesicles were separated from 
the TGN donor compartment by velocity centrifugation through 
sucrose, the top fractions (1–5) were pooled, and LDCVs were 
further separated from constitutive secretory vesicles by equi­
librium sedimentation through sucrose. In PC12 cells treated 
with control siRNA, the constitutively secreted 
35SO4
­HSPG 
migrates in fractions 8–10, whereas LDCV protein 
35SO4
­SgII 
migrates in fractions 12–13 (Fig. 7 C). In contrast, AP­3 RNAi 
shifts the 
35SO4
­SgII signal toward lighter fractions partially 
overlapping with the 
35SO4
­HSPG signal. The redistribution of 
35SO4
­SgII shows that AP­3 promotes sorting into LDCVs at 
the level of the TGN.
The shift in LDCV proteins to lighter fractions suggests 
that in the absence of AP­3, LDCV cargo may sort instead to 
constitutive secretory vesicles. Indeed, vesicles with dense cores 
still bud without AP­3, and the presence of a dense core may 
account for their intermediate density. To reconcile the mild 
morphological phenotype of AP­3 RNAi with the severe func­
tional effect on secretion, we examined the distribution of mem­
brane proteins implicated in regulated exocytosis. Equilibrium 
sedimentation  through  sucrose  shows  that  the  v­SNAREs 
VAMP2 and ­3 migrate over a wide range of fractions with enrich­
ment in lighter membranes, but the distribution shows no clear 
change with RNAi for AP­3 (Fig. 8 A). In contrast, AP­3 RNAi 
redistributes the calcium sensor synaptotagmin 1 (Fernández­
Chacón et al., 2001; Chapman, 2008) from heavy to light mem­
branes (Fig. 8), a dramatic effect that presumably contributes to 
the gross disturbance in regulated secretion.
Discussion
An RNAi screen identifies genes required 
for sorting to the RSP
Using a sensitive reporter, RNAi in Drosophila S2 cells, and 
high­throughput  flow  cytometry,  we  identified  a  remarkably 
the internal compartments briefly with NH4Cl to reveal the total 
fluorescence and selected cells with similar expression levels 
(Fig. 5 B). In addition, we briefly lowered the external pH to 
5.5, and observed substantially increased quenching of VMAT2­
pHluorin after AP­3 knockdown (Fig. 5 B), which is consistent 
with increased cell surface expression. Cells treated with control 
siRNA also show very few spontaneous exocytotic events in the 
absence of stimulation but massive exocytosis in response to de­
polarization. In contrast, AP­3 RNAi significantly increases base­
line, constitutive exocytosis of VMAT2 and greatly reduces the 
response to stimulation (Fig. 5, A, C, and D; and Videos 1 and 2).
AP-3 contributes to LDCV biogenesis
How does AP­3 contribute to regulated secretion? The loss of 
AP­3 might have pleiotropic effects that indirectly influence the 
regulation of LDCV exocytosis. Alternatively, AP­3 may have a 
primary role in LDCV production that influences their composi­
tion and, consequently, their fusion. We therefore characterized 
the properties of LDCVs produced in the absence of this adaptor. 
Separating  PC12  membranes  by  equilibrium  sedimentation 
through sucrose, we find that the knockdown of AP­3 reduces the 
proportion of SgII migrating in fractions that would, in control 
cells, contain LDCVs. AP­3 RNAi also shifts SgII to lighter frac­
tions (Fig. 6 A). In separate experiments, we took advantage of 
cotransfected ANF­GFP to assay more (80) gradient fractions 
using a fluorescent plate reader and to achieve higher resolution. 
Like endogenous SgII, ANF­GFP shows a shift toward light 
fractions with AP­3 RNAi (Fig. 6 B). Importantly, the RNAi has 
no effect on migration of the synaptic vesicle protein synapto­
physin (Fig. 6 A). Thus, AP­3 has a specific effect on the proper­
ties of LDCVs, suggesting that any defect in fusion results from 
a change in their composition and therefore their formation.
To determine whether AP­3 RNAi affects the number of   
LDCVs and their morphology, we used electron microscopy. The 
analysis shows a substantial reduction in the number and density of 
LDCVs in PC12 cells subjected to knockdown of AP­3 (Fig. 6 C), 
which is consistent with a role for AP­3 in their production. As sug­
gested by previous work (Grabner et al., 2006), the size of LDCVs 
also increases significantly with a reduction in AP­3 (Fig. 6 D).
To assess a specific role for AP­3 in LDCV production, 
we used metabolic labeling with 
35SO4
, which occurs spe­
cifically within the TGN (Baeuerle and Huttner, 1987), where   
LDCVs form. Sulfation labels both SgII and the constitutively 
secreted  heparan  sulfate  proteoglycan  (HSPG;  Tooze  and 
Huttner, 1990). 4 h after labeling, 
35SO4
­HSPG essentially dis­
appears from control PC12 cells, which is consistent with con­
stitutive release, and this does not change with AP­3 RNAi   
(Fig. 7 A). In contrast, 
35SO4
­SgII undergoes prolonged storage in 
control PC12 cells. However, in cells lacking AP­3, 
35SO4
­SgII 
peak (black line), expressed as a percentage of total area. *, P < 0.01 relative to control by two-tailed Student’s t test (n = 3 transfections). (C and D) PC12 
cells were transfected twice with either control or AP-3 siRNA and processed for electron microscopy 2 d after the second transfection. (C) Low magnifica-
tion electron micrographs show a large reduction in the number of LDCVs (arrowheads) of cells transfected with AP-3 siRNA (right) relative to controls (left). 
Bar graphs indicate the number of LDCVs per cell in the section (left) and LDCV density (right). *, P < 0.0005; **, P < 0.000001 (n = 20 cells/condition). 
(D) Higher magnification electron micrographs show that AP-3 RNAi increases the size of LDCVs. Bar graphs indicate the corrected diameters (left) and 
areas (right) of both the entire LDCV and the electron-dense core (Parsons et al., 1995). (bottom) The LDCV area is presented as a frequency histogram.   
*, P < 0.01 (n = 205–221 LDCVs/condition). Bars, 200 nm.
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Figure 7.  AP-3 RNAi diverts SgII to constitutive secretory vesicles budding from the TGN. (A and B) PC12 cells were transfected twice with 50 nM AP-3 or 
control siRNA, labeled for 5 min with 0.5–1 mCi/ml 
35SO4, and either harvested directly (pulse [p]) or incubated at 37°C for 4 h (chase [c]) in complete 
medium containing 1.6 mM nonradioactive Na2SO4. (A) Separation of duplicate cell extracts by electrophoresis followed by autoradiography shows that 
after 4 h, control cells store almost all of the labeled SgII. In contrast, AP-3 RNAi dramatically reduces the storage of SgII with no effect on the constitutively 
secreted HSPG. Error bars indicate the percent decline in cellular content of labeled protein after the chase relative to just after the pulse. *, P < 0.02 rela-
tive to control by two-tailed Student’s t test (n = 3). (B) Aliquots of media from the times indicated confirm the constitutive secretion of HSPG unaffected by 
AP-3 RNAi and the constitutive release of SgII produced by AP-3 RNAi. (C) PC12 were transfected and labeled with 
35SO4 as described in A, incubated 
at 37°C for 15 min after the pulse, and a postnuclear supernatant separated by velocity sedimentation through a 0.3–1.2 M continuous sucrose gradient, 
with the TGN-derived vesicles in fractions 1–5 separated further by equilibrium sedimentation on a 0.5–2 M continuous sucrose gradient. (left) 500 µl 
fractions were collected from the top of the gradient, and 50 µl aliquots were separated by electrophoresis followed by fluorography. (right) Only fractions 
with significant amounts of radioactivity are shown, and the labeled HSPG and SgII in each fraction are expressed as a percentage of the total labeled 
protein on the gradient. The amount of SgII in the HSPG peak increases with AP-3 RNAi, and the bar graph indicates the area under the HSPG peak as 
a percentage of the area under the entire SgII curve (inset). *, P < 0.05 relative to control by two-tailed Student’s t test. The data indicate means of three 
independent transfections, and error bars indicate SEM.1183 Biogenesis of the regulated secretory pathway • Asensio et al.
Among the dsRNA whose effects are occluded by the   
DE/AA mutation (class III genes), we identified a carboxypepti­
dase that influences regulated exocytosis. Interestingly, previous 
work has suggested that the membrane­associated protease 
carboxypeptidase E promotes sorting to the RSP of multiple pep­
tides, including proopiomelanocortin and insulin (Cool et al., 
1997;  Cawley  et  al.,  2004).  However,  the  carboxypeptidase 
identified in this screen is required for the trafficking of VMAT, a 
polytopic membrane protein that does not undergo proteolytic 
processing, and for the regulated secretion of ANF. In addition, 
the gene identified in this study shows stronger similarity to the 
carboxypeptidase B than the E family.
AP-3 is required for sorting to the 
regulated pathway
The screen also identified multiple subunits of the adaptor protein 
AP­3. The knockdown of these subunits produces some of the 
strongest effects on surface expression of dVMAT, and the most 
profound on ANF, with increased constitutive and reduced regu­
lated secretion. Furthermore, we find that AP­3 RNAi increases 
VMAT2 surface expression in PC12 cells and markedly impairs 
the regulated secretion of SgII from this mammalian cell line.
Like other class III genes, the DE/AA mutation occludes 
the effect of AP­3 RNAi, suggesting that they act in the same 
small number of genes required for sorting to the RSP. Most of 
these have a known role in membrane trafficking, but only four 
are required for regulated secretion.
Classifying the genes further in terms of their functional 
interaction with the cytosolic dileucine­like motif in VMAT (and 
in particular the upstream acidic residues), we found that the 
knockdown of two genes (nup93 and pp1-13c) increases cell 
surface expression of both DE/AA and wt dVMAT (class I).   
Although a subunit of the nuclear pore complex, nup93 exhibits 
structural  similarity  to  coat  proteins,  and  one  subunit  of  the   
COPII coat indeed belongs to a subcomplex of the nuclear pore 
(Devos et al., 2004; Brohawn et al., 2008). Considering its localiza­
tion to the nuclear envelope, nup93 may thus have a role in sorting   
to the RSP at the level of the endoplasmic reticulum, where sort­
ing may begin (Martínez­Menárguez et al., 1999). Knockdown of 
the catalytic subunit in PP1 also impairs regulated secretion, and 
several kinases have been implicated in sorting at the TGN.   
In addition to lipid kinases, which synthesize the phosphatidyl­
inositol­4­phosphate required for recruitment of multiple pro­
teins to the Golgi complex (De Matteis and Luini, 2008), protein 
kinase D contributes to constitutive secretion (Liljedahl et al., 
2001). PP1 may promote sorting to the RSP by antagonizing the 
function of these kinases, thereby regulating the production of 
LDCVs and constitutive secretory vesicles.
Figure 8.  AP-3 RNAi affects the membrane composi-
tion of LDCVs. PC12 cells were transfected twice with 
50 nM AP-3 or control siRNA, and the postnuclear super-
natant obtained 2–3 d after the second transfection   
separated by equilibrium sedimentation through 0.6–
1.6 M sucrose. (A) Fractions were collected from the 
top of the gradient and assayed for VAMP2, VAMP3, 
and synaptotagmin 1 (syt1) by quantitative fluorescent 
immunoblotting. (B) The amounts in each fraction in light 
membranes (peak I) and LDCV fractions (peak II) are 
expressed as a percentage of total gradient immuno-
reactivity. AP-3 RNAi greatly reduces the LDCV peak of 
synaptotagmin 1 and shifts the synaptotagmin 1 immuno-
reactivity toward lighter fractions. *, P < 0.05 relative to 
control by two-tailed Student’s t test (n = 3 transfections). 
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with 
35SO4
. At this time, vesicles containing 
35SO4
­SgII and   
­HSPG have budded from the TGN, and equilibrium sedimenta­
tion can be used to separate light constitutive secretory vesicles 
(containing HSPG) from heavier immature LDCVs (containing 
SgII). Using this assay, we find that the loss of AP­3 redistrib­
utes SgII into lighter fractions. Although the missorting is again 
not complete, it is similar to that observed at steady state for 
SgII and for EE/AA rat VMAT2 (Krantz et al., 2000). These re­
sults indicate that AP­3 has a role in sorting to LDCVs at the 
level of the TGN.
AP­3 has generally been considered to function within the 
endocytic rather than biosynthetic pathway. AP­3 mediates sort­
ing to lysosomes and LROs such as melanosomes and secretory 
lysosomes (Newell­Litwa et al., 2007; Dell’Angelica, 2009), 
and these membranes, in contrast to LDCVs, form within the 
endocytic pathway. Loss of AP­3 also affects the behavior of 
lytic granules, the LROs of cytotoxic T cells, but does not influ­
ence the sorting of soluble cargo into lytic granules, and this has 
again  been  attributed  to  a  defect  in  the  endocytic  pathway   
(Clark et al., 2003). Consistent with this role, AP­3 localizes 
primarily to endosomes (Peden et al., 2004). However, lower 
levels also localize to other sites, including the Golgi com­
plex (Dell’Angelica et al., 1997; Peden et al., 2004). In addi­
tion, AP­3 contains neural and ubiquitous subunits, and we do 
not know whether they have the same subcellular distribution.   
It is also possible that AP­3 on endosomes promotes sorting to 
the  RSP  by  recycling  to  the TGN  components  required  for 
LDCV formation, but AP­3 promotes recycling to lysosomes and 
LROs, not the Golgi complex (Dell’Angelica, 2009). Although 
unanticipated from previous work, the requirement for AP­3 in 
sorting to the RSP now argues for a functional role in the bio­
synthetic pathway, at the TGN.
Supporting a role in the biosynthetic pathway, AP­3 func­
tions at the TGN in yeast (Cowles et al., 1997; Stepp et al., 
1997). In contrast to the main lysosomal targeting pathway that 
delivers hydrolases such as carboxypeptidase Y to the vacuole 
through an endosomal intermediate, AP­3 contributes to an   
alternative pathway that targets alkaline phosphatase directly to 
the vacuole. However, this pathway has been considered spe­
cific to yeast. The evidence of a role for AP­3 in sorting to the 
RSP now suggests that a component of the alternative lysosome­
targeting pathway participates directly in the formation of regu­
lated secretory vesicles from the TGN of metazoans. Because the   
alternative lysosome­targeting pathway lacks an endosomal   
intermediate, it may have been particularly well suited to mini­
mize the loss of soluble cargo and acquire the capacity for regu­
lated release of proteins that mediate extracellular signaling.
Despite the effects of AP­3 loss on LDCV number, mor­
phology, and density, vesicles with a dense core still form both 
in PC12 cells after RNAi and in mocha mice. What then ac­
counts for the disproportionately severe functional effect on 
regulated exocytosis? The budding assay suggests that proteins 
normally segregated to the RSP intermix with those destined for 
constitutive secretion, and this may account for the intermediate 
density and increased size of vesicles with a dense core. Support­
ing this possibility, we find that the loss of AP­3 redistributes 
synaptotagmin 1 to fractions even lighter than those containing 
pathway. Consistent with this, a previous study has suggested 
that the interaction of a dileucine motif with AP­3 requires acidic 
residues 4 and 5 upstream (Janvier et al., 2003) at the same posi­
tions found in dVMAT, mammalian VMAT2, and phogrin. More­
over, a recent study on the closely related adaptor AP­2 suggests 
a structural basis for the more stringent requirement of AP­3 for 
upstream acidic residues (Kelly et al., 2008). Although it can be 
difficult to assess the relevance of adaptor–cargo interactions 
identified in vitro, the study now provides functional evidence 
that AP­3 interacts directly with the extended dileucine motif in 
VMAT2 to mediate its sorting into the RSP.
The results show that the loss of AP­3 disrupts the regu­
lated exocytosis of LDCVs. AP­3 RNAi almost eliminates the 
regulated release of SgII from PC12 cells, with only a minimal 
effect on the amount secreted constitutively. However, because 
AP­3 knockdown reduces the cellular content of SgII, it in­
creases the proportion that undergoes constitutive release. Im­
portantly, the loss of AP­3 greatly reduces the storage of granin 
proteins in mocha mice and PC12 cells, establishing the physio­
logical relevance of the findings in vitro and excluding potential 
off­target effects of the RNAi. In addition, the analysis of 
VMAT2 exocytosis by direct optical imaging demonstrates both 
an increase in constitutive release and a dramatic reduction in 
regulated release produced by the loss of AP­3.
AP­3 has previously been suggested to influence the mor­
phology of LDCVs. The mocha mutation increases the size of 
chromaffin granules by direct electrochemical measurement of 
quantal monoamine release and electron microscopy (Grabner 
et al., 2006). We also observe enlarged LDCVs after AP­3 knock­
down in PC12 cells. However, Grabner et al. (2006) examined   
release only after the direct application of calcium to permeabil­
ized cells and did not address the regulation of release. Thus, the   
results presented in this study provide the first evidence that AP­3 
is required for regulated secretion.
AP-3 influences LDCV formation
To understand how the loss of AP­3 disrupts regulated exo­
cytosis, we examined the effect on LDCVs. In addition to the 
increased diameter, we observe a major reduction (50%) in 
the number of LDCVs. Soluble LDCV cargo (endogenous SgII 
and transfected ANF­GFP) also shifts toward lighter fractions 
by equilibrium sedimentation. These effects strongly suggest 
that AP­3 contributes to LDCV formation or maturation rather 
than simply to their regulated exocytosis.
We took advantage of labeling with 
35SO4
 to determine 
how AP­3 influences the fate of secretory vesicles formed at the 
TGN. In contrast to control cells that release negligible amounts 
of SgII even after 4 h of chase, AP­3 RNAi results in the release 
of SgII within 30 min after budding from the TGN, with no   
effect  on  the  constitutively  released  HSPG.  Because  LDCV 
maturation continues long after budding from the TGN, the 
rapid release of SgII suggests a role for AP­3 that precedes mat­
uration, such as sorting within the TGN. Consistent with an ear­
lier locus for AP­3 action, LDCV maturation is apparently not 
required for the regulation of exocytosis (Tooze et al., 1991).
To address a role for AP­3 in sorting at the TGN, we ex­
amined the formation of secretory vesicles 15 min after labeling 1185 Biogenesis of the regulated secretory pathway • Asensio et al.
and has been widely used for high-throughput, cell-based screens (Malo   
et al., 2006), with a script written for the statistical software “R” to automate 
the analysis. To minimize false positives, a stringent z score > 3.0 (P < 
0.0014) was used to identify dsRNA sequences positive in the screen. The 
screen was also performed twice, once using transiently transfected S2 
cells, and once with stable transformants. The positives from both screens 
were combined, and those with few remaining cells or altered GFP expres-
sion  were  removed  from  further  consideration,  leaving  18  sequences 
(0.25% of the original library) available for further study.
To exclude off-target effects, we retested the 18 positives with non-
overlapping dsRNA sequences from the same gene. In each experiment, 
the cumulative frequency distribution of fluorescence ratios from individual 
cells was plotted, compared with control RNAi, and statistical significance 
was analyzed by Kolmogorov-Smirnov. We applied the stringent Bonfer-
roni correction for 19 samples (18 positives + control) and considered as 
positive a P value < 0.0025 in at least two independent experiments.   
A typical dataset consisted of 50–500 cells per dsRNA treatment in the 
screen and 1,000–5,000 cells in the retest. Of 18 positives from the origi-
nal screen, 16 showed a consistent increase in dVMAT cell surface expres-
sion on retest and were thus considered true positives.
Secretion assays
S2 cells transfected with ANF-GFP were washed with PBS, resuspended in 
Tyrode’s medium (119 mM NaCl, 2.5 mM KCl, 2 mM CaCl2, 2 mM 
MgCl2, 30 mM glucose, and 25 mM Hepes, pH 7.4), split equally into two 
tubes, incubated in the presence or absence of 100 µg/ml LPS (Sigma- 
Aldrich) for 1 h at 27°C, sedimented, and the fluorescence from 200 µl   
aliquots of the supernatant was measured in triplicate using a plate reader 
(Tecan), with stimulated secretion expressed as a percentage of the respec-
tive unstimulated condition.
siRNAs  to  rat  AP-31  (antisense,  5-UUCUUGGUCAUGAUCCA-
UGTG-3;  sense  control,  5-CAUGGAUCAUGACCAAGAATT-3)  were 
transfected twice (at 50 nM) 2 d apart, and the PC12 cells were washed   
2–3 d later and incubated in Tyrode’s buffer containing 2.5 mM K
+ (basal) or 
90 mM K
+ (stimulated) for 30 min at 37°C. The supernatant was collected, 
cell lysates were prepared as previously described (Li et al., 2005), and the 
samples were analyzed by quantitative fluorescent immunoblotting.
Adrenal gland granin content
Mocha mice (Jackson ImmunoResearch Laboratories, Inc.) were back-
crossed to C57BL/6 to remove grizzled and Pde6b
rd1 alleles, and the   
adrenal glands were homogenized in 150 mM NaCl, 50 mM Tris-HCl,   
pH 8.0, 1% NP-40, 0.5% sodium deoxycholate, and protease inhibitors   
including 1 mM EGTA and 1 mM PMSF. After sedimentation at 14,000 g  
to remove nuclei and cell debris, 20 µg protein was separated by electro-
phoresis through polyacrylamide, transferred to nitrocellulose, and the mem-
branes were immunoblotted for SgII and CgA, with actin as loading control 
and the appropriate secondary antibodies conjugated to IRDye800 (Rock-
land Immunochemicals, Inc.). The immunoreactivity was quantified by im-
aging with an Odyssey system (LI-COR Biosciences) and ImageJ (National 
Institutes of Health), and results were normalized to actin.
TIRF microscopy
For TIRF microscopy, PC12 cells plated onto glass chambers coated with 
poly-l-lysine were transfected with 50 nM siRNAs to rat AP-3, and 2 d 
later, cotransfected with siRNAs and VMAT2-pHluorin. After an additional 
3 d, images were collected for 100 ms at 2 Hz and room temperature   
using a TIRF inverted microscope (TE2000E; Nikon) with a Plan Apo NA 
1.49 100× oil objective and an electron-multiplying charge-coupled de-
vice camera (QuantEM; Photometrics). To reveal surface and total VMAT2 
fluorescence, cells were incubated sequentially with Tyrode’s solution con-
taining 25 mM MES, pH 6.5, and then 50 mM NH4Cl, pH 7.4. To exam-
ine basal and regulated release, cells were incubated in Tyrode’s solution 
containing 2.5 mM or 90 mM K
+, respectively, for 1 min each. Videos   
1 and 2 were acquired in Advanced Research (NIS-Elements), exported as 
AVI files, and image sequences were analyzed using ImageJ software.
Density gradient fractionation
Equilibrium sedimentation through sucrose was performed as previously 
described (Waites et al., 2001). In brief, a postnuclear supernatant was 
prepared from PC12 cells by homogenization with a ball-bearing device 
(8-µm clearance), loaded onto a 0.6–1.6 M continuous sucrose gradient, 
and sedimented at 30,000 rpm in a rotor (SW41; Beckman Coulter) for 
14–16 h at 4°C. Fractions (200 µl each) were collected from the top di-
rectly into a 96-well plate (Costar), and ANF-GFP fluorescence was read 
soluble LDCV cargo. As a major calcium sensor for regulated 
exocytosis of LDCVs (Voets et al., 2001; Schonn et al., 2008), 
the change in synaptotagmin distribution presumably contrib­
utes to the loss of regulated release. In addition, previous work 
on the trafficking of synaptotagmin 1 has identified a conserved 
C­terminal  dileucine  motif  with  upstream  acidic  residues 
(EEVDAML) that may account for the dependence on AP­3 
(Blagoveshchenskaya et al., 1999; Jarousse and Kelly, 2001). 
However, the effect of AP­3 deficiency seems more profound 
than that produced by loss of synaptotagmin 1 (Voets et al., 
2001; Schonn et al., 2008), strongly suggesting that AP­3 also 
affects the distribution of other proteins that influence the mode 
of exocytosis.
Materials and methods
Molecular biology
EGFP or mCherry were fused to the N terminus of HA-dVMAT (provided by 
D. Krantz, University of California, Los Angeles, Los Angeles, CA) to pro-
duce GFP-/HA-dVMAT and mCherry-/HA-dVMAT, respectively. The DE/AA 
mutation was introduced by overlap extension PCR. ANF-GFP was pro-
vided by E. Levitan (University of Pittsburgh, Pittsburgh, PA), and ss-GFP 
was constructed by amplifying the ss of ANF and fusing it directly to GFP. 
For expression in Drosophila S2 cells, all cDNAs were subcloned into 
pAc5.1 (Invitrogen). For expression in rat PC12 cells, all cDNAs were sub-
cloned into the chicken actin-based vector pCAGGS.
Cell culture
Drosophila S2 cells were maintained in Schneider medium (Invitrogen) 
supplemented with 10% heat-inactivated fetal bovine serum at 27°C in a 
humidified incubator. Transfection of S2 cells was performed using either 
Nucleofection (Lonza) for transient expression or Fugene HD reagent (Roche) 
for stable expression, both according to the manufacturer’s instructions. For 
stable expression, S2 cells were cotransfected with GFP-/HA-dVMAT and 
pCoHygro (Invitrogen) in a 10:1 molar ratio and selected in 300 µg/ml 
hygromycin for 4 wk. PC12 cells were maintained in DME-H21 medium 
supplemented with 10% horse serum and 5% calf serum at 37°C. Transfec-
tion of PC12 cells was performed using Lipofectamine 2000 (Invitrogen) 
according to the manufacturer’s instructions.
Antibodies and immunofluorescence
The HA.11 mouse monoclonal antibody was obtained from Covance, the 
M2-Flag mouse monoclonal antibody from Sigma-Aldrich, the SgII rabbit 
antibody from Meridian Life Science, the chromogranin A goat antibody 
from Santa Cruz Biotechnology, Inc., the 3A mouse monoclonal antibody 
from BD, the VAMP2, -3, and synaptotagmin 1 antibodies from Synaptic 
Systems GmbH, the actin mouse monoclonal antibody from Millipore, the 
Zenon Alexa Fluor 647 labeling kit from Invitrogen, and the synaptophysin 
(p38) monoclonal antibody from Sigma-Aldrich.
Screen and analysis
S2 cells transfected with GFP-dVMAT-HA were treated in 96-well plates 
with dsRNA prepared from the University of California San Francisco (San 
Francisco, CA) DmRNAi library version 1 (7,216 genes; Goshima et al., 
2007). After growth for 72 h, the cells were again treated with the same 
dsRNA, incubated for an additional 72 h, and surface HA expression was 
determined by adding external HA.11 antibody bound to Zenon Alexa 
Fluor 647 (1:1,000) for 2 h in standard medium, removing the unbound 
antibody with two washes, and subjecting the cells to high-throughput flow 
cytometry  (lsrII;  BD)  for  both  GFP  and  Alexa  Fluor  647  fluorescence.   
The ratio of Alexa Fluor 647 to GFP fluorescence was calculated for indi-
vidual cells, and the mean ratio was calculated from all cells in the well.
Assuming that treatment with most dsRNA does not affect surface 
dVMAT expression, the mean Alexa Fluor 647/GFP fluorescence ratio 
from all wells of a plate should resemble the ratio from cells without dsRNA 
and, thus, serve as a within-plate negative control. Z scores were deter-
mined by subtracting the overall mean Alexa Fluor 647/GFP ratio (derived 
from the entire plate) from the ratios for individual wells, normalizing to the 
standard deviation determined from the mean ratios of all wells in the 
plate. This analysis limits statistical artifacts caused by interplate variability JCB • VOLUME 191 • NUMBER 6 • 2010   1186
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Electron microscopy
PC12 cells were plated onto aclar film discs (Pella) coated with poly-l-lysine, 
transfected twice with 50 nM siRNA, washed with calcium-/magnesium-
free PBS 2 d after the second transfection and fixed with 2.5% glutaraldehyde 
in calcium-/magnesium-free PBS. The discs were washed three times with 
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with 1% osmium tetroxide in cacodylate buffer containing 1.6% potas-
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